MetaADEDB 2.0 @ LMMD
Cyproterone Acetate
(UWFYSQMTEOIJJG-FDTZYFLXSA-N)
Structure
SMILES
CC(=O)O[C@@]1(CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2C=C(C2=CC(=O)[C@H]3[C@@H]([C@]12C)C3)Cl)C(=O)C
Type(s)
Approved; Investigational
ATC code(s)
G03HA01; G03HB01
Molecular Formula:
C24H29ClO4
Molecular Weight:
416.938
Log P:
4.6076
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
0
TPSA:
60.44
CAS Number(s):
427-51-0
Synonym(s)
1.
Cyproterone Acetate
2.
Androcur
3.
Cyproterone Acetate, (1 alpha,2 alpha)-Isomer
4.
Cyproterone Acetate, (1 alpha,2 alpha,9 beta,10 alpha)-Isomer
5.
Cyproterone Acetate, (17 alpha)-Isomer
External Link(s)
MeSHD017373
PubChem Compound9880
BindingDB50094569
ChEBI50743
CHEMBLCHEMBL139835
DrugBankDB04839
DrugCentral766
IUPHAR/BPS Guide to PHARMACOLOGY2865
KEGGdr:D01368
ZINC3814423
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Acne Vulgaris

View details

CTD
2ActinomycosisOFFSIDES
3Acute respiratory failureOFFSIDES
4Adenomatous Polyps8706251CTD
5Adrenal Cortex Diseases8706251CTD
6AgeusiaOFFSIDES
7Alanine Aminotransferase IncreasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
8Alopecia20053802CTD
9AmphetaminesOFFSIDES
10Anion gap abnormalOFFSIDES
11AnorexiaOFFSIDES
12AnuriaOFFSIDES
13ApathyOFFSIDES
14AscitesCanada Vigilance: 1Canada Vigilance
OFFSIDES
15Aspartate Aminotransferase IncreasedCanada Vigilance: 1Canada Vigilance
16AstheniaCanada Vigilance: 1Canada Vigilance
OFFSIDES
17Atrial FlutterOFFSIDES
18Autoimmune hepatitisOFFSIDES
19Blood albumin abnormalOFFSIDES
20Blood albumin decreasedOFFSIDES
21Blood alkaline phosphatase increasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
22Blood creatinine increasedOFFSIDES
23Blood iron decreasedOFFSIDES
24Blood phosphorusOFFSIDES
25Blood sodium increasedOFFSIDES
26Blood sodiumOFFSIDES
27Blood urea increasedOFFSIDES
28Blood uric acid decreasedOFFSIDES
29Budd-Chiari Syndrome20038345CTD
30Burning sensationOFFSIDES
31Carcinogenesis1347714CTD
32Cardiovascular Diseases2935644
2942707
CTD
33Chemical and Drug Induced Liver Injury

View details

CTD
34CholangiolitisOFFSIDES
35CholestasisCanada Vigilance: 111573856CTD
Canada Vigilance
36ChromaturiaCanada Vigilance: 1Canada Vigilance
37Chronic left ventricular failureOFFSIDES
38Cleft Palate6461082CTD
39Cognition Disorders15142146CTD
40Coronary Artery Disease16323982CTD
41Cytolytic hepatitisOFFSIDES
42Deep Vein ThrombosisCanada Vigilance: 1Canada Vigilance
43Disseminated Intravascular CoagulationCanada Vigilance: 1Canada Vigilance
44Drug resistanceOFFSIDES
45Dyslipidemias16323982CTD
46Edema2935644CTD
47Endometrial hypertrophyOFFSIDES
48Epidural lipomatosisOFFSIDES
49EpilepsyOFFSIDES
50Erectile dysfunction6205409
10646878
CTD
51EscharOFFSIDES
52Eye painOFFSIDES
53FatigueCanada Vigilance: 1Canada Vigilance
54Fibrosis10333116CTD
55Gamma-Glutamyltransferase IncreasedCanada Vigilance: 1Canada Vigilance
OFFSIDES
56General physical health deteriorationOFFSIDES
57GranulocytosisOFFSIDES
58Gynecomastia6205409CTD
59Hepatic Encephalopathy2563116CTD
60Hepatic necrosisCanada Vigilance: 1Canada Vigilance
61Hepatitis B positiveOFFSIDES
62HepatitisCanada Vigilance: 120063830CTD
OFFSIDES
Canada Vigilance
63Hepatorenal SyndromeCanada Vigilance: 1Canada Vigilance
64Hirsutism6205409
12615818
15269926
CTD
65HydronephrosisOFFSIDES
66HyporeflexiaOFFSIDES
67Hypothalamic Diseases10333116CTD
68Hypotrichosis10660647CTD
69Infusion site necrosisOFFSIDES
70Intermittent ClaudicationOFFSIDES
71IridocyclitisOFFSIDES
72Iron binding capacity total abnormalOFFSIDES
73Kidney Cortex Necrosis465307
503094
CTD
74Lipase decreasedOFFSIDES
75Liver Failure, Acute10489919CTD
76Liver Failure8958378CTD
77Liver Neoplasms, Experimental1691053
8453718
CTD
78Liver diseases8181926CTD
79Liver neoplasms1347714
8706251
25058030
CTD
80Lower respiratory tract infectionCanada Vigilance: 1Canada Vigilance
81Malignant neoplasm progressionOFFSIDES
82Meningioma20053802CTD
OFFSIDES
83Mental impairmentOFFSIDES
84Muscle WeaknessOFFSIDES
85Muscle necrosisOFFSIDES
86Neural Tube Defects6461082CTD
87OphthalmoplegiaOFFSIDES
88Ovarian enlargementOFFSIDES
89PROTHROMBIN TIMEOFFSIDES
90Pancreatic Diseases8706251CTD
91ParaplegiaOFFSIDES
92PhlebitisOFFSIDES
93PneumoniaCanada Vigilance: 1Canada Vigilance
94Polycystic Ovary Syndrome12615818CTD
95Precancerous Conditions1691053CTD
96Prolactinoma8784065
20227072
CTD
97Prostatic Hyperplasia6205409CTD
98Prostatic Neoplasms

View details

CTD
99Psychomotor skills impairedOFFSIDES
100Pulmonary EmbolismCanada Vigilance: 12945082CTD
Canada Vigilance
101Pulmonary InfarctionCanada Vigilance: 1Canada Vigilance
102Pulmonary congestionCanada Vigilance: 1Canada Vigilance
103Renal Artery Obstruction11966649CTD
104Respiratory FailureOFFSIDES
105Respiratory distressCanada Vigilance: 1Canada Vigilance
106Retinal Vein Occlusion10660647CTD
107RhabdomyolysisOFFSIDES
108SchizophreniaOFFSIDES
109Scrotal irritationOFFSIDES
110SinusitisOFFSIDES
111SubileusOFFSIDES
112Tongue bitingOFFSIDES
113Transferrin decreasedOFFSIDES
114Transferrin saturation increasedOFFSIDES
115Urologic Diseases6461082CTD
116Uterine Diseases8706251CTD
117Venous Thromboembolism12615818
15269926
17537215
CTD
118Visual disturbanceOFFSIDES
119Weight Gain6205409CTD
120jaundiceCanada Vigilance: 12145371
2563116
CTD
Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.